These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 22664639)

  • 1. Impact of synergistic polymorphisms in adrenergic receptor-related genes and cardiovascular events in patients with dilated cardiomyopathy.
    Ogimoto A; Okayama H; Nagai T; Suzuki J; Inoue K; Nishimura K; Shigematsu Y; Tabara Y; Miki T; Higaki J
    Circ J; 2012; 76(8):2003-8. PubMed ID: 22664639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms of the beta-1 and beta-2 adrenergic receptors in Polish patients with idiopathic dilated cardiomyopathy.
    Paczkowska A; Szperl M; Małek Ł; Mazurkiewicz Ł; Skóra E; Grzybowski J; Roszczynko M; Bilińska Z; Tesson F; Ruzyłło W
    Kardiol Pol; 2009 Mar; 67(3):235-41. PubMed ID: 19378229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ser49Gly of beta1-adrenergic receptor is associated with effective beta-blocker dose in dilated cardiomyopathy.
    Magnusson Y; Levin MC; Eggertsen R; Nyström E; Mobini R; Schaufelberger M; Andersson B
    Clin Pharmacol Ther; 2005 Sep; 78(3):221-31. PubMed ID: 16153393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta1- and beta2-adrenergic receptor polymorphisms affect susceptibility to idiopathic dilated cardiomyopathy.
    Forleo C; Sorrentino S; Guida P; Romito R; De Tommasi E; Iacoviello M; Pitzalis M
    J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):589-95. PubMed ID: 17667029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms of norepinephrine transporter and adrenergic receptor alpha1D are associated with the response to beta-blockers in dilated cardiomyopathy.
    Nonen S; Okamoto H; Fujio Y; Takemoto Y; Yoshiyama M; Hamaguchi T; Matsui Y; Yoshikawa J; Kitabatake A; Azuma J
    Pharmacogenomics J; 2008 Feb; 8(1):78-84. PubMed ID: 17404580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta1-adrenergic receptor gene polymorphisms in Mexican patients with idiopathic dilated cardiomyopathy.
    Fragoso JM; Rodríguez-Pérez JM; González J; Cruz D; Pérez-Méndez O; de Jesus García J; de la Peña A; Arce M; Reyes PA; Vargas-Alarcón G
    Exp Mol Pathol; 2006 Jun; 80(3):279-82. PubMed ID: 16487965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No positive association between adrenergic receptor variants of alpha2cDel322-325, beta1Ser49, beta1Arg389 and the risk for heart failure in the Japanese population.
    Nonen S; Okamoto H; Akino M; Matsui Y; Fujio Y; Yoshiyama M; Takemoto Y; Yoshikawa J; Azuma J; Kitabatake A
    Br J Clin Pharmacol; 2005 Oct; 60(4):414-7. PubMed ID: 16187973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of beta-adrenergic receptor polymorphisms and progression to heart failure in patients with idiopathic dilated cardiomyopathy.
    Forleo C; Resta N; Sorrentino S; Guida P; Manghisi A; De Luca V; Romito R; Iacoviello M; De Tommasi E; Troisi F; Rizzon B; Guanti G; Rizzon P; Pitzalis MV
    Am J Med; 2004 Oct; 117(7):451-8. PubMed ID: 15464701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha2C-adrenoceptor polymorphism is associated with improved event-free survival in patients with dilated cardiomyopathy.
    Regitz-Zagrosek V; Hocher B; Bettmann M; Brede M; Hadamek K; Gerstner C; Lehmkuhl HB; Hetzer R; Hein L
    Eur Heart J; 2006 Feb; 27(4):454-9. PubMed ID: 16299019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressive effect of the Gly389 allele of the beta1-adrenergic receptor gene on the occurrence of ventricular tachycardia in dilated cardiomyopathy.
    Iwai C; Akita H; Shiga N; Takai E; Miyamoto Y; Shimizu M; Kawai H; Takarada A; Kajiya T; Yokoyama M
    Circ J; 2002 Aug; 66(8):723-8. PubMed ID: 12197595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms of the beta1-adrenergic receptor predict exercise capacity in heart failure.
    Wagoner LE; Craft LL; Zengel P; McGuire N; Rathz DA; Dorn GW; Liggett SB
    Am Heart J; 2002 Nov; 144(5):840-6. PubMed ID: 12422153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic polymorphisms of beta1- and alpha2C-adrenergic receptors and the risk of congestive heart failure.
    Small KM; Wagoner LE; Levin AM; Kardia SL; Liggett SB
    N Engl J Med; 2002 Oct; 347(15):1135-42. PubMed ID: 12374873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms of beta-adrenoceptor and natriuretic peptide receptor genes influence the susceptibility to and the severity of idiopathic dilated cardiomyopathy in a Chinese cohort.
    Wang L; Lu L; Zhang F; Chen Q; Shen W
    J Card Fail; 2010 Jan; 16(1):36-44. PubMed ID: 20123316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenergic receptor genotype influences heart failure severity and β-blocker response in children with dilated cardiomyopathy.
    Reddy S; Fung A; Manlhiot C; Tierney ES; Chung WK; Blume E; Kaufman BD; Goldmuntz E; Colan S; Mital S
    Pediatr Res; 2015 Feb; 77(2):363-9. PubMed ID: 25406899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-adrenergic receptor polymorphisms in susceptibility, response to treatment and prognosis in heart failure: implication of ethnicity.
    Pereira SB; Velloso MW; Chermont S; Quintão MM; Nunes Abdhala R; Giro C; Oliveira E Alves T; Camacho V; De Fátima Maia Contarato L; Pena FM; Balieiro HM; Garcia ML; Da Nóbrega AC; Ribeiro GS; Mesquita ET
    Mol Med Rep; 2013 Jan; 7(1):259-65. PubMed ID: 23064657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Phenotype and Genotype Associations With Improvement in Left Ventricular Function in Dilated Cardiomyopathy.
    Verdonschot JAJ; Hazebroek MR; Wang P; Sanders-van Wijk S; Merken JJ; Adriaansen YA; van den Wijngaard A; Krapels IPC; Brunner-La Rocca HP; Brunner HG; Heymans SRB
    Circ Heart Fail; 2018 Nov; 11(11):e005220. PubMed ID: 30571196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A polymorphism in the endothelin-A receptor gene predicts survival in patients with idiopathic dilated cardiomyopathy.
    Herrmann S; Schmidt-Petersen K; Pfeifer J; Perrot A; Bit-Avragim N; Eichhorn C; Dietz R; Kreutz R; Paul M; Osterziel KJ
    Eur Heart J; 2001 Oct; 22(20):1948-53. PubMed ID: 11601839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic polymorphisms of beta1 and alpha2C-adrenergic receptors and the influence on left ventricular ejection fraction response to beta-blocker therapy in heart failure.
    Lobmeyer MT; Gong Y; Terra SG; Beitelshees AL; Langaee TY; Pauly DF; Schofield RS; Hamilton KK; Herbert Patterson J; Adams KF; Hill JA; Aranda JM; Johnson JA
    Pharmacogenet Genomics; 2007 Apr; 17(4):277-82. PubMed ID: 17496726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of beta1-adrenergic receptor polymorphisms on susceptibility to heart failure, arrhythmogenesis, prognosis, and response to beta-blocker therapy.
    Biolo A; Clausell N; Santos KG; Salvaro R; Ashton-Prolla P; Borges A; Rohde LE
    Am J Cardiol; 2008 Sep; 102(6):726-32. PubMed ID: 18773997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenergic receptor genotypes influence postoperative outcomes in infants in the Single-Ventricle Reconstruction Trial.
    Ramroop R; Manase G; Lu D; Manase D; Chen S; Kim R; Lee T; Mahle WT; McHugh K; Mitchell M; Tristani-Firouzi M; Wechsler SB; Wilder NS; Zak V; Lafreniere-Roula M; Newburger JW; Gaynor JW; Russell MW; Mital S
    J Thorac Cardiovasc Surg; 2017 Nov; 154(5):1703-1710.e3. PubMed ID: 28734628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.